Thursday, May 9 12:30–1:45pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 1)
Thursday, May 9 2–4:15pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 2)
Friday, May 10 9:45–10:45am
Beyond Gut Instincts: Improving Patient Outcomes in Irritable Bowel Syndrome with Constipation
Thursday, May 9 12:30–1:45pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 1)
Thursday, May 9 2–4:15pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 2)
Friday, May 10 7:30–8:30am
Patient-Centered Clinical Care for African Americans: Cardiovascular Disease
Thursday, May 9 7:30–8am
Thursday, May 9 10–11am
Alzheimer Disease in Primary Care: Early Identification and New Anti-Amyloid Treatment Options
Thursday, May 9 2–4:15pm
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 2)
Thursday, May 9 4:30–6pm
Taking the Dialogue to the Next Level: Facilitating Open Communication About Obesity
Friday, May 10 10:45–11:45am
Common Dermatologic Challenges in Primary Care: Tips and Tricks for Management
Thursday, May 9 8–9am
Two Sides of the Same Coin: A Dual-Focused Approach for Diabetes and Weight Management
Thursday, May 9 11am–12pm
USPSTF Recommendation Updates: An Ounce of Prevention in Primary Care
Thursday, May 9 4:30–6pm
Taking the Dialogue to the Next Level: Facilitating Open Communication About Obesity
Disclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Charles E. Argoff, MD, FABPM
- AbbVie, Amgen, Averitas Pharma, Biohaven, Grunenthal, Impel Pharmaceuticals, Kowa Pharmaceuticals America, Lilly, Lundbeck, Nevro, and Teva., Speaker; AbbVie, Amgen, Averitas Pharma, Clexio Biosciences, EnZen Therapeutics, Kowa, Lundbeck, Nevro, Tremeau Pharmaceuticals, Tris Pharma, Vertex and Xgene Pharma., Advisor; AbbVie, Amgen, Lilly, Lundbeck, and Teva., Researcher; Neumentum, PainScript, and Tris Pharma, Consultant; Pfizer and Trevena., Stock Holder (publicly traded company)
- Rachel M. Bond, MD, FACC
- No relevant financial relationships disclosed.
- Darren M. Brenner, MD, FACG, AGAF, RFF
- AbbVie, Consultant; AbbVie, Speaker; Alnylam, Advisor; Anji, Advisor; Ardelyx, Advisor; Ardelyx, Consultant; Ardelyx, Speaker; Arena, Advisor; Bayer, Consultant; Gemelli, Consultant; Ironwood, Consultant; Ironwood, Speaker; Laborie, Consultant; Mahana, Consultant; Owlstone, Consultant; QoL Medical, Independent Contractor; Redhill, Consultant; Redhill, Speaker; Salix, Advisor; Salix, Consultant; Salix, Speaker; Takeda, Consultant; Takeda, Speaker; Vibrant, Advisor; Vibrant, Consultant
- Oscar A. de Leon-Casasola, MD
- Kowa Pharmaceuticals, Advisor; Kowa Pharmaceuticals, Consultant
- Gregory L. Hall, MD
- No relevant financial relationships disclosed.
- Pallavi Joshi, DO, MA
- No relevant financial relationships disclosed.
- Pamela Kushner, MD, FAAFP
- Abbott, Stock Holder (publicly traded company); Janssen, Lilly/BI, AstraZeneca, Bayer, GlaxoSmithKline, Phathom, Astellas, Haleon, and Novo Nordisk., Speaker; Lilly, Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, Corcept, Haleon, and Bayer., Consultant; Novo Nordisk, Lilly, Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, Abbott, Phathom, Bausch/SALIX, Intuity, Pfizer, and Janssen., Advisor
- Gagan Mahajan, MD
- No relevant financial relationships disclosed.
- Joynita R. Nicholson, DO, DABOM, FOMA
- No relevant financial relationships disclosed.
- Katharina Shaw, MD, FAAD
- Information to come
- Katherine Sherif, MD
- No relevant financial relationships disclosed.
- Rashmi B. Halker Singh, MD, FAHS, FAAN
- Pfizer, Advisor
- Tina K. Thethi, MD, MPH
- Bayer and Eli Lilly and Company, Speaker; Bayer and Novo Nordisk, Researcher; Novo Nordisk, Consultant
- Charles Vega, MD, FAAFP
- GlaxoSmithKline and Boehringer Ingelheim, Consultant
- Laila Woc-Colburn, MD
- No relevant financial relationships disclosed.
Other Disclosures
Jennifer Green, MD (Planner): Consultant for Lilly, Novo Nordisk, and AstraZeneca; Consultant and Researcher for Boehringer Ingelheinm
All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.